S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.YJMCC.2005.06.018PMID 16236309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes

  2005cited by this paper
• S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts

  2004cited by this paper
• Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.

  2004cited by this paper
• Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart.

  2003cited by this paper
• The C Terminus (Amino Acids 75–94) and the Linker Region (Amino Acids 42–54) of the Ca2+-binding Protein S100A1 Differentially Enhance Sarcoplasmic Ca2+ Release in Murine Skinned Skeletal Muscle Fibers*

  2003influential reference
• Transgenic Overexpression of the Ca2+-binding Protein S100A1 in the Heart Leads to Increased in Vivo Myocardial Contractile Performance*

  2003influential reference
• Extracellular S100A1 Protein Inhibits Apoptosis in Ventricular Cardiomyocytes via Activation of the Extracellular Signal-regulated Protein Kinase 1/2 (ERK1/2)*

  2003cited by this paper
• Impaired Cardiac Contractility Response to Hemodynamic Stress in S100A1-Deficient Mice

  2002cited by this paper
• The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes

  2002cited by this paper
• The Relationship between Intracellular [Ca2+] and Ca2+ Wave Characteristics in Permeabilised Cardiomyocytes from the Rabbit

  2002cited by this paper
• Overexpression of FK506-Binding Protein FKBP12.6 in Cardiomyocytes Reduces Ryanodine Receptor–Mediated Ca2+ Leak From the Sarcoplasmic Reticulum and Increases Contractility

  2001cited by this paper
• S100A1: A regulator of myocardial contractility

  2001influential reference
• Purification of the Ca2+-binding protein S100A1 from myocardium and recombinant Escherichia coli.

  2000cited by this paper
• PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

  2000cited by this paper
• Comparison of Na+-Ca2+ exchange current elicited from isolated rabbit ventricular myocytes by voltage ramp and step protocols

  1999cited by this paper
• The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation.

  1998cited by this paper
• The effect of tetracaine on spontaneous Ca2+ release and sarcoplasmic reticulum calcium content in rat ventricular myocytes.

  1997cited by this paper
• Modulation of Cardiac Ryanodine Receptors by Sorcin*

  1997cited by this paper
• Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle.

  1997cited by this paper
• Measurement of sarcoplasmic reticulum Ca2+ content and sarcolemmal Ca2+ fluxes in isolated rat ventricular myocytes during spontaneous Ca2+ release

  1997cited by this paper
• The effect of tetracaine on supontaneous Ca2+ release and sarcoplasmic reticulum calcium content in rat ventricular myocytes

  1997cited by this paper
• Temperature and relative contributions of Ca transport systems in cardiac myocyte relaxation.

  1996cited by this paper
• Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy.

  1996cited by this paper
• Steady-state twitch Ca2+ fluxes and cytosolic Ca2+ buffering in rabbit ventricular myocytes.

  1996cited by this paper
• Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes.

  1995cited by this paper
• The relative contributions of different intracellular and sarcolemmal systems to relaxation in rat ventricular myocytes.

  1993cited by this paper
• A mechanism for the effects of caffeine on Ca2+ release during diastole and systole in isolated rat ventricular myocytes.

  1990cited by this paper
• S100a0 (alpha alpha) protein in cardiac muscle. Isolation from human cardiac muscle and ultrastructural localization.

  1988cited by this paper
• S100a0, (αα) protein in cardiac muscle

  1988cited by this paper
• S100ao (alpha alpha) protein is mainly located in the heart and striated muscles.

  1985cited by this paper
• S100ao (αα) protein is mainly located in the heart and striated muscles

  1985cited by this paper
• A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels.

  1980cited by this paper

• Cryo-EM Brings the Mechanisms of Activation, Inactivation, and Inhibition of Ryanodine Receptors into Focus.

  2026cites this paper
• Regulation of actin cytoskeleton by Ca2+-binding S100 proteins.

  2025cites this paper
• Life-long creatine deficiency leads to augmented sarcoplasmic reticulum calcium release but not heart failure.

  2025cites this paper
• Structural insights into the regulation of RyR1 by S100A1

  2024cites this paper
• S100A1ct: A Synthetic Peptide Derived From S100A1 Protein Improves Cardiac Performance and Survival in Preclinical Heart Failure Models

  2024cites this paper
• S100 proteins in cardiovascular diseases

  2023cites this paper
• Changes of calcium cycling in HFrEF and HFpEF

  2023cites this paper
• S100A1ct: a synthetic peptide derived from human S100A1 protein improves cardiac contractile performance and survival in pre-clinical heart failure models

  2023cites this paper
• Cardiac-targeted rAAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in post-ischemic hearts

  2023cites this paper
• Restoration of β-adrenergic responsivity in the aging heart.

  2023cites this paper
• S100A1 is Involved in Myocardial Injury Induced by Exhaustive Exercise

  2021cites this paper
• Simulation of the Positive Inotropic Peptide S100A1ct in Aqueous Environment by Gaussian Accelerated Molecular Dynamics.

  2021cites this paper
• Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?

  2020cites this paper
• Molecular Basis of S100A1 Activation and Target Regulation Within Physiological Cytosolic Ca2+ Levels

  2020cites this paper
• S100 family proteins in inflammation and beyond.

  2020cites this paper
• Unbalance Between Sarcoplasmic Reticulum Ca2 + Uptake and Release: A First Step Toward Ca2 + Triggered Arrhythmias and Cardiac Damage

  2020cites this paper
• Current Landscape of Heart Failure Gene Therapy

  2019cites this paper
• B-type natriuretic peptide and its role in altering Ca2+-regulatory proteins in heart failure—mechanistic insights

  2019cites this paper
• S100 proteins in obesity: liaisons dangereuses

  2019cites this paper
• Gene Therapy and Genomic Application in Heart Disease

  2018cites this paper
• The Role of Sorcin in Excitation-Contraction Coupling in Normal and Diseased Hearts

  2017influential citation
• Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia‐Reperfusion

  2017cites this paper
• The characterization of a novel S100A1 binding site in the N-terminus of TRPM1.

  2016cites this paper
• Influence of doxazosin on biosynthesis of S100A6 and atrial natriuretic factor peptides in the heart of spontaneously hypertensive rats

  2016cites this paper
• S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor·Calmodulin Complex*

  2016influential citation
• S100A1 transgenic treatment of acute heart failure causes proteomic changes in rats

  2016influential citation
• Erratum: Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression

  2016cites this paper
• Therapeutic Applications of Calcium Metabolism Modulation in Heart Disease.

  2016cites this paper
• Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression

  2016cites this paper
• Ultrasound-Mediated S100A6 Gene Therapy Ameliorates Myocardial Ischemia/Reperfusion (I/R) Injury

  2016influential citation
• S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.

  2015cites this paper
• Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation

  2015cites this paper
• Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology.

  2015cites this paper
• Differential effects of S100 proteins A2 and A6 on cardiac Ca(2+) cycling and contractile performance.

  2014cites this paper
• A novel needleless liquid jet injection methodology for improving direct cardiac gene delivery: An optimization of parameters, AAV mediated therapy and investigation of host responses in ischemic heart failure

  2014influential citation
• S100A1: a major player in cardiovascular performance.

  2014influential citation
• S 100 A 1 acts positive inotropic and prevents Ca 2 + triggered after-contractions in a model of Engineered Heart Tissue

  2013cites this paper
• Luo and Anderson Mechanisms of Altered Ca 2 + Handling in Heart Failure

  2013cites this paper
• Mechanisms of Altered Ca2+ Handling in Heart Failure

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion.

  2013cites this paper
• Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1.

  2013cites this paper
• Targeting Sarcoplasmic Reticulum Calcium ATPase by Gene Therapy

  2013cites this paper
• Ovariectomy enhances SR Ca²⁺ release and increases Ca²⁺ spark amplitudes in isolated ventricular myocytes.

  2012cites this paper
• Targeting S100A1 in heart failure

  2012cites this paper
• Functional evidence for an active role of B-type natriuretic peptide in cardiac remodelling and pro-arrhythmogenicity.

  2012cites this paper
• Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy

  2012cites this paper
• The Impact of Aging and Ovariectomy on Cardiac Contractile Function in Isolated Ventricular Myocytes

  2012cites this paper
• Modulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1.

  2011influential citation
• S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials.

  2011cites this paper
• Calmodulin and S100A1 fine tune skeletal muscle E-C coupling. Focus on "Modulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1".

  2011cites this paper
• S100A1 and calmodulin regulation of ryanodine receptor in striated muscle.

  2011cites this paper
• The Inotropic Peptide &bgr;ARKct Improves &bgr;AR Responsiveness in Normal and Failing Cardiomyocytes Through G&bgr;&ggr;-Mediated L-Type Calcium Current Disinhibition

  2011cites this paper
• Sex differences in mechanisms of cardiac excitation–contraction coupling

  2010cites this paper
• Ca 2 + signaling in mouse cardiomyocytes with ablated S 100 A 1 protein

  2010influential citation
• S100A1: A Multifaceted Therapeutic Target in Cardiovascular Disease

  2010influential citation
• The Inotropic Peptide (cid:1) ARKct Improves (cid:1) AR Responsiveness in Normal and Failing Cardiomyocytes Through G (cid:1)(cid:2) -Mediated L-Type Calcium Current Disinhibition

  2010cites this paper
• S100A1: A Regulator of Striated Muscle Sarcoplasmic Reticulum Ca2+ Handling, Sarcomeric, and Mitochondrial Function

  2010cites this paper
• S100A1: a pluripotent regulator of cardiac and vascular function.

  2010cites this paper
• Age-associated changes in excitation-contraction coupling are more prominent in ventricular myocytes from male rats than in myocytes from female rats.

  2010cites this paper
• The rapidly expanding CREC protein family: members, localization, function, and role in disease

  2009cites this paper
• Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein.

  2009cites this paper
• Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction.

  2009cites this paper
• S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.

  2009cites this paper
• S100A1: Structure, Function, and Therapeutic Potential.

  2009cites this paper
• Lack of S 100 A 1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction

  2009cites this paper
• S100A1 Binds to the Calmodulin-binding Site of Ryanodine Receptor and Modulates Skeletal Muscle Excitation-Contraction Coupling*

  2008cites this paper
• Designing heart performance by gene transfer.

  2008cites this paper
• Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies.

  2008cites this paper
• S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products

  2008cites this paper
• S 100 A 8 and S 100 A 9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products

  2008cites this paper
• S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.

  2007cites this paper
• Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue

  2007cites this paper
• S100A1: a calcium-modulating inotropic prototype for future clinical heart failure therapy.

  2007cites this paper
• S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes.

  2007influential citation
• Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.

  2007cites this paper
• Regulation of Na+/Ca2+ Exchange Current in the Normal and Failing Heart

  2007cites this paper
• Pathologies involving the S100 proteins and RAGE.

  2007cites this paper
• CALL FOR PAPERS Regulation of Cardiac Muscle Contraction S 100 A 1 : a novel inotropic regulator of cardiac performance . Transition from molecular physiology to pathophysiological relevance

  2007cites this paper
• S100A1 gene transfer in myocardium.

  2006cites this paper
• Integration of calcium with the signaling network in cardiac myocytes.

  2006cites this paper
• Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction

  2006cites this paper
• S 100 A 1 Gene Therapy Preserves in Vivo Cardiac Function after Myocardial Infarction

  2005cites this paper
• S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.

  2005cites this paper